Pharmacoeconomic Studies: Pitfalls and Problems
- 1 January 1996
- journal article
- review article
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 12 (1) , 22-30
- https://doi.org/10.1017/s0266462300009351
Abstract
The literature on economic evaluation of Pharmaceuticals is growing rapidly. Although there have been substantial methodologic advances, there remain serious problems and pitfalls. This presentation focuses on three aspects, i.e., use (and abuse) of evaluation studies, methodologic problems, and the quality of published studies.Keywords
All Related Versions
This publication has 20 references indexed in Scilit:
- Economic Evaluation of healthcare: A half‐way technologyHealth Economics, 1994
- Persons vs years: Two ways of eliciting implicit weightsHealth Economics, 1994
- Measuring utility values for QALYs: Two methodological issuesHealth Economics, 1993
- The Reliability of Cost-Utility Estimates in Cost-Per-QALY League TablesPharmacoEconomics, 1993
- Discounting in Cost-Effectiveness Analysis of Healthcare ProgrammesPharmacoEconomics, 1993
- Economic Analysis in Randomized Control TrialsMedical Care, 1992
- Economic Analysis as an Aid to Subsidisation DecisionsPharmacoEconomics, 1992
- Economic Evaluation of PharmaceuticalsPharmacoEconomics, 1992
- Exposure of the wound--a safe economy in the NHSPublished by Oxford University Press (OUP) ,1987
- Guidelines for the clinical and economic evaluation of health care technologiesSocial Science & Medicine, 1986